Jamile M. Shammo

Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5q

Azra Raza, James A. Reeves, Eric J. Feldman et al. · Blood · 2007 · 422 citations · Full text

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, Kevin A. David, Irene Helenowski et al. · Journal of Clinical Oncology · 2010 · 314 citations · Full text

Solid Organ Transplantation, Immunology, Surgery +17

RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia

Jason X. Cheng, Li Chen, Yuan Li et al. · Nature Communications · 2018 · 225 citations · Full text

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

Hagop M. Kantarjian, Pierre Fenaux, Mikkael A. Sekeres et al. · Journal of Clinical Oncology · 2009 · 200 citations

Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry

Hubert Schrezenmeier, Alexander Röth, David J. Araten et al. · Annals of Hematology · 2020 · 141 citations · Full text